Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1980 2
1981 2
1982 3
1984 7
1985 4
1986 2
1987 8
1988 6
1989 9
1990 12
1991 8
1992 17
1993 11
1994 21
1995 32
1996 29
1997 28
1998 32
1999 49
2000 39
2001 60
2002 63
2003 53
2004 88
2005 167
2006 162
2007 211
2008 185
2009 259
2010 318
2011 351
2012 413
2013 472
2014 525
2015 595
2016 624
2017 795
2018 892
2019 923
2020 1173
2021 1445
2022 1699
2023 1608
2024 589

Text availability

Article attribute

Article type

Publication date

Search Results

12,485 results

Results by year

Filters applied: . Clear all
Page 1
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.
Jiang YZ, Ma D, Jin X, Xiao Y, Yu Y, Shi J, Zhou YF, Fu T, Lin CJ, Dai LJ, Liu CL, Zhao S, Su GH, Hou W, Liu Y, Chen Q, Yang J, Zhang N, Zhang WJ, Liu W, Ge W, Yang WT, You C, Gu Y, Kaklamani V, Bertucci F, Verschraegen C, Daemen A, Shah NM, Wang T, Guo T, Shi L, Perou CM, Zheng Y, Huang W, Shao ZM. Jiang YZ, et al. Among authors: jin x. Nat Cancer. 2024 Feb 12. doi: 10.1038/s43018-024-00725-0. Online ahead of print. Nat Cancer. 2024. PMID: 38347143
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.
Fan L, Wang ZH, Ma LX, Wu SY, Wu J, Yu KD, Sui XY, Xu Y, Liu XY, Chen L, Zhang WJ, Jin X, Xiao Q, Shui RH, Xiao Y, Wang H, Yang YS, Huang XY, Cao AY, Li JJ, Di GH, Liu GY, Yang WT, Hu X, Xia Y, Liang QN, Jiang YZ, Shao ZM. Fan L, et al. Among authors: jin x. Lancet Oncol. 2024 Feb;25(2):184-197. doi: 10.1016/S1470-2045(23)00579-X. Epub 2024 Jan 8. Lancet Oncol. 2024. PMID: 38211606 Clinical Trial.
ALS-linked C9orf72-SMCR8 complex is a negative regulator of primary ciliogenesis.
Tang D, Zheng K, Zhu J, Jin X, Bao H, Jiang L, Li H, Wang Y, Lu Y, Liu J, Liu H, Tang C, Feng S, Dong X, Xu L, Yin Y, Dang S, Wei X, Ren H, Dong B, Dai L, Cheng W, Wan M, Li Z, Chen J, Li H, Kong E, Wang K, Lu K, Qi S. Tang D, et al. Among authors: jin x. Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2220496120. doi: 10.1073/pnas.2220496120. Epub 2023 Dec 8. Proc Natl Acad Sci U S A. 2023. PMID: 38064514
12,485 results
You have reached the last available page of results. Please see the User Guide for more information.